lucence insight promo 12
Cancer ScreeningBlood sample4 weeks after cut-off, excluding weekends and holidays
Lucence Insight Promo 12
A focused liquid biopsy that examines a 12-gene panel from circulating tumour DNA in a blood sample. It provides a non-invasive way to detect key cancer-related genetic alterations.
Sample
Blood
Results
4 weeks after cut-off, excluding weekends and holidays
Prep
Check details
Follow-up
Optional add-on
What this test detects
12-gene circulating tumour DNA (ctDNA) panel
Next-generation sequencing · plasma
Mutation and alteration status
Male cancer types: esophageal, kidney (clear cell), bladder, prostate, nasopharyngeal, thyroid, lung, liver, stomach, pancreatic, gastrointestinal stromal tumor (GIST), colorectal
Female cancer types: ovarian, cervical, endometrial, breast, nasopharyngeal, thyroid, lung, liver, stomach, pancreatic, gastrointestinal stromal tumor (GIST), colorectal
When to get this test
Non-invasive tumour profiling
Gives genomic insights from a blood draw when a tissue biopsy is not ideal.
Guiding targeted therapy
Detects actionable alterations within the panel that may inform treatment choices.
Focused genomic testing
Covers a defined set of key genes relevant to certain cancers.
How to prepare
01
No special preparation needed.
02
Bring any relevant pathology or prior test reports if available.
Common questions
How long do results take?
Results are typically ready within 14 to 21 days due to the genomic analysis involved.
How is this different from the larger panel?
This option analyses 12 genes, while the larger panel covers more genes for a broader genomic picture.
Is a tissue sample needed?
No, this liquid biopsy uses a blood sample, so no tumour tissue biopsy is required.